NEURAL MECHANISMS UNDERLYING NICOTINE DEPENDENCE

被引:97
作者
BALFOUR, DJK
机构
[1] Department of Pharmacology and Clinical Pharmacology, University of Dundee Medical School, Ninewells Hospital, Dundee
关键词
D O I
10.1111/j.1360-0443.1994.tb03738.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
There is little doubt that many habitual smokers find it difficult to quit the habit because they have become addicted to the nicotine present in the smoke. This paper addresses some of the pharmacological mechanisms underlying this addiction and discusses how an understanding of these mechanisms may contribute to the more effective use of nicotine replacement therapy during smoking cessation. It considers critically the evidence that the ''rewarding'' properties of nicotine, which serve to reinforce drug-seeking behaviour, are related to stimulation of the mesolimbic dopamine system of the brain. The critique focuses specifically on the evidence that many central nicotinic receptors, including those which mediate the effects of the drug on dopamine secretion, are readily desensitized by chronic exposure to agonist and that hypotheses which assume that nicotine inhaled from tobacco smoke invariably results in stimulation of the receptors must be treated with caution. Nicotinic receptors in the brain are, however, heterogeneous in nature with different molecular structures and pharmacologies. It is concluded that the reinforcing properties of nicotine sought by smokers may reflect both stimulation and desensitization of the different nicotinic receptor populations, and that smokers may adjust their smoking habits to achieve the balance of receptor stimulation and desensitization which they find most reinforcing. It seems likely that the efficacy of the different nicotine formulations during the treatment of smoking cessation may also reflect their ability to stimulate or desensitize brain nicotinic receptors.
引用
收藏
页码:1419 / 1423
页数:5
相关论文
共 25 条
[1]  
BALFOUR DJK, 1991, BRIT J ADDICT, V86, P489
[2]   A COMPARISON OF THE EFFECTS OF NICOTINE AND (+)-AMPHETAMINE ON RAT BEHAVIOR IN AN UNSIGNALED SIDMAN AVOIDANCE SCHEDULE [J].
BALFOUR, DJK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (04) :257-260
[3]  
BALFOUR DJK, 1986, PSYCHOPHARMACOLOGY, V90, P528
[4]  
BALFOUR DJK, 1991, BIOL BASES DRUG TOLE, P121
[5]   THE EFFECTS OF ACUTE AND REPEATED NICOTINE TREATMENT ON NUCLEUS-ACCUMBENS DOPAMINE AND LOCOMOTOR-ACTIVITY [J].
BENWELL, MEM ;
BALFOUR, DJK .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :849-856
[6]   INFLUENCE OF TETRODOTOXIN AND CALCIUM ON CHANGES IN EXTRACELLULAR DOPAMINE LEVELS EVOKED BY SYSTEMIC NICOTINE [J].
BENWELL, MEM ;
BALFOUR, DJK ;
LUCCHI, HM .
PSYCHOPHARMACOLOGY, 1993, 112 (04) :467-474
[7]  
BENWELL MEM, 1994, CLIN INVESTIGATOR, V72, P233
[8]   EVIDENCE THAT TOBACCO SMOKING INCREASES THE DENSITY OF (-)-[H-3]NICOTINE BINDING-SITES IN HUMAN-BRAIN [J].
BENWELL, MEM ;
BALFOUR, DJK ;
ANDERSON, JM .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (04) :1243-1247
[9]   SMOKING-ASSOCIATED CHANGES IN THE SEROTONERGIC SYSTEMS OF DISCRETE REGIONS OF HUMAN BRAIN [J].
BENWELL, MEM ;
BALFOUR, DJK ;
ANDERSON, JM .
PSYCHOPHARMACOLOGY, 1990, 102 (01) :68-72
[10]   EFFECTS OF NICOTINE ADMINISTRATION AND ITS WITHDRAWAL ON PLASMA-CORTICOSTERONE AND BRAIN 5-HYDROXYINDOLES [J].
BENWELL, MEM ;
BALFOUR, DJK .
PSYCHOPHARMACOLOGY, 1979, 63 (01) :7-11